3 Medical Instruments Stocks to Buy Amid Improving Industry Trends
https://www.zacks.com/commentary/2255364/3-medical-instruments-stocks-to-buy-amid-improving-industry-trends?cid=CS-ZC-FT-industry_outlook-2255364
Apr 15, 2024 - The Zacks Medical - Instruments industry is expected to gain from the rising adoption of smart healthcare options, including genAI. However, supply issues and staffing shortages continue to disrupt growth. EW, DXCM and STE appear well-poised to brave the challenges.
0
Here's Why Steris (STE) is Poised for a Turnaround After Losing -9.06% in 4 Weeks
https://www.zacks.com/stock/news/2252552/here-s-why-steris-ste-is-poised-for-a-turnaround-after-losing-9-06-in-4-weeks?cid=CS-ZC-FT-tale_of_the_tape|rsi-2252552
Apr 09, 2024 - The heavy selling pressure might have exhausted for Steris (STE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
0
Here's Why Investors Should Retain STERIS (STE) Stock for Now
https://www.zacks.com/stock/news/2247607/here-s-why-investors-should-retain-steris-ste-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2247607
Mar 28, 2024 - Investors are optimistic about STERIS (STE) on strong Healthcare business performance and raised 2024 guidance.
0
Here's Why Investors Should Retain STERIS (STE) Stock for Now
https://www.zacks.com/stock/news/2232656/here-s-why-investors-should-retain-steris-ste-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2232656
Feb 27, 2024 - Investors are optimistic about STERIS (STE) on continuous recovery of healthcare procedures and upbeat 2024 guidance.
0
Why Steris (STE) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2226893/why-steris-ste-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2226893
Feb 15, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Why Steris (STE) is a Top Growth Stock for the Long-Term
https://www.zacks.com/stock/news/2224796/why-steris-ste-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2224796
Feb 12, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0
Compared to Estimates, Steris (STE) Q3 Earnings: A Look at Key Metrics
https://www.zacks.com/stock/news/2222953/compared-to-estimates-steris-ste-q3-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2222953
Feb 07, 2024 - The headline numbers for Steris (STE) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Medical Products Stocks' Earnings Due on Feb 7: STE, PAHC & NVST
https://www.zacks.com/stock/news/2221839/medical-products-stocks-earnings-due-on-feb-7-ste-pahc-nvst?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2221839
Feb 06, 2024 - Medical Products companies' quarterly results are likely to reflect a year-over-year decline in earnings. Let's see how STE, PAHC and NVST fare this time.
0
Steris (STE) Reports Next Week: Wall Street Expects Earnings Growth
https://www.zacks.com/stock/news/2218775/steris-ste-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2218775
Jan 31, 2024 - Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Pages: 1
Page 1